case 1: a patient with disease progression on hydroxyurea
Published 8 years ago • 363 plays • Length 4:54Download video MP4
Download video MP3
Similar videos
-
5:14
case 1: a pv patient with disease progression on hydroxyurea
-
5:10
ruxolitinib for relapsed/refractory or hydroxyurea-intolerant polycythemia vera patients
-
5:43
moving beyond hydroxyurea for polycythemia vera
-
6:21
a case of hydroxyurea-intolerant polycythemia vera
-
2:59
using hydroxyurea in a patient with polycythemia vera
-
5:13
ruxolitinib for relapsed/refractory or hydroxyurea-intolerant polycythemia vera patients _old
-
20:15
hydroxyurea intolerance/resistance in polycythemia vera
-
6:07
available treatment options for patients with pv
-
3:00
assessing response to hydroxyurea treatment
-
9:19
debate: should jak inhibitors use be limited to hydroxyurea-resistant/intolerant pv patients? - no
-
4:51
pv: clinical use of hydroxyurea
-
17:31
how do you treat pv patients that fail hydroxyurea (hu)?
-
4:36
treatment for pv: moving beyond hydroxyurea
-
8:55
ruxolitinib for relapsed/refractory or hu-intolerant polycythemia vera
-
5:12
lydia pecker: hydroxyurea and diminished ovarian reserve in young patients with sickle cell anemia
-
1:40
challenges and options for patients with hydroxyurea-resistant pv
-
21:43
hydroxyurea intolerance/resistance in polycythemia vera
-
6:51
resistance to targeted-tki treatment in patients with cml
-
4:52
treating pv with jak inhibition now and in the future